Method of biochip for simultaneous testing avian influenza infection of human and fowls
An avian influenza virus and biochip technology, applied in biological testing, measuring devices, material inspection products, etc., can solve problems such as time-consuming and labor-intensive, and achieve the effect of protecting people's lives, property and animal resources.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] A: Prepare the activated 3D chip substrate (produced by Shenzhen Saier Biotechnology Co., Ltd.);
[0025] B: Fragments of various subtypes of avian influenza to be spotted: namely common hemagglutinin fragments H1, H3, H5, H7, H9, neuraminidase fragments N1, N2, nucleoprotein NP, non-structural protein NS1. Specimens are prepared with monoclonal antibodies of H1, H3, H5, H7, H9 and N1, N2, NP, and NS1, that is, the ascites is purified and diluted to different concentrations, and then mixed in proportion and all mixed, as the specimen to be tested. Meanwhile, normal human serum and chicken serum were used as controls, respectively. In practical application, the specimen can be human serum, chicken serum. and require it to be carried out in a specific laboratory. These fragment samples are all antigen fragments expressed by genetic engineering (co-developed by Shenzhen Saier Biotechnology Co., Ltd. and a research institute), all of which are expressed in yeast, with goo...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com